(Q52168640)

English

The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.

scientific article published in May 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

author name string

K K Szumlinski

1

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

I M Maisonneuve

2

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

S D Glick

3

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

864

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

1

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

13-23

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Long-term sensitization to the excitatory effects of morphine. A motility study in post-dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Opioid and GABA modulation of accumbens-evoked ventral pallidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Drug addiction as dopamine-dependent associative learning disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Effects of morphine on intracranial self-stimulation to various brain stem loci

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Mechanisms of Antiaddictive Actions of Ibogainea

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

(±)-18-Methoxycoronaridine: A Novel Iboga Alkaloid Congener Having Potential Anti-Addictive Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Opioids excite dopamine neurons by hyperpolarization of local interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

A role for sensitization in craving and relapse in cocaine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Long-term sensitization to the activation of cerebral delta-opioid receptors by the deltorphin Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 in rats exposed to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Ibogaine neurotoxicity: a re-evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Ibogaine induces glial activation in parasagittal zones of the cerebellum.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Sex Differences in Ibogaine Antagonism of Morphine-induced Locomotor Activity and in Ibogaine Brain Levels and Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Behavioral sensitization is induced by intravenous self-administration of cocaine by rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

Anticipatory hyperexcitability and tolerance to the narcotizing effect of morphine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902069-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(00)02069-2

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/10793182

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52168640&oldid=1463708327"